Home
>
National Drug Code (NDC)
>
nicotine polacrilex
nicotine polacrilex - 11673-190-05 - (Nicotine Polacrilex)
Drug Information of nicotine polacrilex
| Product NDC: | 11673-190 |
| Proprietary Name: | nicotine polacrilex |
| Non Proprietary Name: | Nicotine Polacrilex |
| Active Ingredient(s): | 4 mg/1 & nbsp; Nicotine Polacrilex |
| Administration Route(s): | ORAL |
| Dosage Form(s): | LOZENGE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of nicotine polacrilex
| Product NDC: | 11673-190 |
| Labeler Name: | Target Corporation |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | ANDA090711 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110312 |
Package Information of nicotine polacrilex
| Package NDC: | 11673-190-05 |
| Package Description: | 3 VIAL in 1 CARTON (11673-190-05) > 24 LOZENGE in 1 VIAL |
NDC Information of nicotine polacrilex
| NDC Code | 11673-190-05 |
| Proprietary Name | nicotine polacrilex |
| Package Description | 3 VIAL in 1 CARTON (11673-190-05) > 24 LOZENGE in 1 VIAL |
| Product NDC | 11673-190 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Nicotine Polacrilex |
| Dosage Form Name | LOZENGE |
| Route Name | ORAL |
| Start Marketing Date | 20110312 |
| Marketing Category Name | ANDA |
| Labeler Name | Target Corporation |
| Substance Name | NICOTINE |
| Strength Number | 4 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
